abstract |
The present invention relates to heterocycles used as selective inhibitors of fibroblast growth factor receptor 4 (FGFR-4), in particular the invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof. ci, and a pharmaceutical composition comprising said compound. |